ASML vs CCCC · P/E 57, $665.37B cap vs rev $35.6M
ASML Holding NV ADR (ASML) versus C4 Therapeutics Inc (CCCC) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. CCCC currently screens at market cap $425.7M.
Not investment advice. Open the ASML and CCCC stock pages for the full models.
Not investment advice.